IPIRA Startups

IPIRA Startups

Valitor Inc.

Brief Description

Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity, and bioactivity. The company's technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. The lead product will be used to improve the treatment of diseases in ophthalmology. The company also has development pipelines for oncology and orthopedics products.

The company was incubated at Berkeley Skydeck, UC Berkeley's...

Two Blades Foundation

Brief Description

2Blades was established as a 501(c)3 charitable organization to implement practical uses of important innovations in plant science that address the rising incidence of crop disease. Working together with world leading scientists in plant-pathogen interactions, 2Blades has scouted and supported the most significant advances in the understanding of plant disease and immunity, as well as enabling technologies to develop disease resistant crops.

Remarkable advances have been realized in plant science over the past twenty years, including genome sequencing,...

TTech Systems, Inc.

Brief Description

TTech Systems, Inc. developed a proprietary, software-based road traffic monitoring system.

As principal programmer analyst for UC Berkeley's Institute of Transportation Studies, founder/inventor Randall Cayford developed TTech's foundational patent-protected software and technologies that turn mobile phone signals and GPS locations into real-time traffic speed information. Cayford was CEO of TTech, until it merged with IntelliOne Technologies in 2004. At IntelliOne, which was headquartered in Atlanta, Georgia, Cayford served as Chief Technology Officer.

...

Tilden Bio

Brief Description

Development of photosynthetic bioproducts including natural plant essential oils, cannabinoids, and biopharmaceutical proteins. The technology has been applied to enhance yields of high-value photosynthetic bioproducts in the UC Berkeley Melis Laboratory.

Formerly known as Tabletop Energy.

Timeline 2019. Company incorporated Inventors

Nico Betterle, Fiona Davies, Cinzia Formighieri, Diego Hidalgo Martinez, Henning Kirst, Andrew Saphire, Hsu Ching Wintz, Andreas Zurbriggen, Anastasios Melis

Thuris Corporation

Brief Description

Thuris Corporation was a biopharmaceutical company focused on medical device solutions to aid in drug development and diagnosis of central nervous system (CNS) disorders including mild cognitive impairment and Alzheimer's disease. Thuris was also developing pharmaceuticals for select CNS orphan and niche indications ranging from ischemia-related conditions, brain inflammation and Huntington's disease. Thuris received 510k FDA clearance for a non-invasive medical device, the NeuroGraph, for diagnosis of neurological and psychiatric disorders over a broad range of brain-...

Texas Fluorescence Labs

Brief Description

Texas Fluorescence Labs was a reagent and assay technologies company, spun out of modern fluorescent calcium indicator discoveries at UC Berkeley. The company specialized in pioneering new approaches to ion channel and ion transporter-focused basic and translational research and provided reagents, assays, and assay development services to scientists, universities, and laboratories worldwide for research in biochemistry, biomolecular screening, microbiology, and neuroscience.

In 2018, UC Berkeley Professor of Chemistry and Biochemistry Roger Tsien shared the Nobel...

Synvivia, Inc.

Brief Description

Synvivia is a synthetic biology company that optimizes cell behavior for gene therapy manufacturing, providing a practical solution for genetically encoded biocontainment. The company is building genetically encoded biocontainment technologies that will enable the widespread use of synthetic biology outside of the laboratory.

The company's technology was developed at UC Berkeley with grants from the NSF and DARPA. The work was published in ACS Synthetic Biology and featured as an Editor’s Choice in Science Magazine. Synvivia has exclusive license to the...

Sunesis Pharmaceuticals Inc.

Brief Description

Sunesis is a biopharmaceutical company focused on the development and future commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. Sunesis has built an experienced cancer drug development organization committed to improving the lives of people with cancer. The company is focused on advancing its novel kinase-inhibitor pipeline, with an emphasis on establishing proof of concept that it's oral non-covalent BTK inhibitor, vecabrutinib (SNS-062), is effective in the treatment of ibrutinib-resistant chronic lymphocytic...

Silicor Materials, Inc.

Brief Description

Silicor Materials was a global leader in the production of solar silicon. The company was headquartered San Jose, California, with a research and development team located in Berlin, Germany.

The organization was founded as a development company in 2006 under the name Calisolar, with the goal of manufacturing low-cost photovoltaic (PV) solar cells from silicon designed specifically for the solar industry (“solar silicon”) rather than electronic-grade polysilicon. Among the company's founding members was solar energy pioneer UC Berkeley Professor of Materials Science...

Silicon Genesis Corporation

Brief Description

Silicon Genesis Corporation, doing business as SiGen, develops substrate technology, processes, and equipment for semiconductor, solar, display, and optoelectronics markets worldwide. The company provides silicon-on-insulators (SOIs), strained-silicon products, and other engineered multi-layer structures for microelectronic and photonics industries for advanced electronic and optoelectronic device applications. Its products include Stand-Alone Plasma-Activation Tool, a small footprint tool that provides a reactive surface to bond silicon wafers and heterogeneous...